drugset / Trial / NCT01229046

Pharmacokinetics and Safety of Ticarcillin-clavulanate in Infants

NCT01229046

Phase 1 Withdrawn Phillip Brian Smith
NaSingle-groupOpen-label

Summary

This study will evaluate the safety, tolerability and PK of ticarcillin-clavulanate in infants \<91 days of age with suspected systemic infection.

Timeline

Start
2010-09
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amoxicillin Other / unclassified 75 mg/kg Intravenous